Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine's Efficiency in the Treatment of Chronic Pain With an Added Inflammatory Component
NCT03513822Phase 3Unknown
- Sponsor
- Radar Therapeutics
- Start
- Feb 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in chronic neuropathic pain, sponsored by Radar Therapeutics. Status: unknown.
02
Drugs
ketamine
03
Conditions
chronic neuropathic pain
Beyond the preview
Go deeper on NCT03513822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03513822.